3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
27
Burkitt Lymphoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
5
Leukemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Myelodysplastic Syndromes
2
Leukemia, Monocytic, Acute
2
Thrombocythemia, Essential
1
Sarcoma, Myeloid
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Neoplasms
1
Lymphoma, T-Cell
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Basophilic, Acute
1
Hematologic Neoplasms
1
Down Syndrome
1
Acute Myeloid Leukemia With KMT2A Rearrangement
1
Interventions
Cyclophosphamide
30
Rituximab
26
Biopsy
23
Specimen Handling
20
Magnetic Resonance Spectroscopy
18
fludarabine
14
Prednisone
13
Vincristine
11
obinutuzumab
10
Lenalidomide
10
Etoposide
10
Doxorubicin
10
Bendamustine Hydrochloride
9
pembrolizumab
7
venetoclax
6
fludarabine phosphate
6
X-Rays
6
Tacrolimus
6
Nuclear Medicine Department, Hospital
6
Dexamethasone
6
Bortezomib
6
trametinib
5
ibrutinib
5
glofitamab
5
acalabrutinib
5
Mycophenolic Acid
5
Gemcitabine
5
Crizotinib
5
Busulfan
5
copanlisib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Daunorubicin
×
90 days
×
Clear all
No trials found.